| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | COR-L23/R23- |
|---|
| Description | The revertant lung cancer cell line COR-L23/R23- was generated by growing the doxorubicin-selected, resistant variant COR-L23/R without drug exposure for 24-28 weeks. The cell line, also known as COR-L23/Rev, overexpresses multidrug resistance -associated protein (MRP), but to a lesser extent than the parent line. It was shown that the cell line has the ability to recover quickly, similar levels of MRP expression and resistance as COR-L23/R after a transient exposure to the MDR-drugs doxorubicin and vincristine. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | CSC-C9496J |
|---|
| Price | |
|---|
| Order / More Info | COR-L23/R23- from CREATIVE BIOARRAY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|